Levosalbutamol
Back to searchMolecule Structure
Scientific Name
Levosalbutamol
Description of the Drug
Levosalbutamol is a beta-2 adrenergic receptor agonist used to treat COPD and asthma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB13139
http://www.drugbank.ca/drugs/DB13139
Brand Name(s)
Not Available
Company Owner(s)
Impax Laboratories Inc, Teva Pharmaceuticals Usa, Mylan Specialty Lp, Teva Parenteral Medicines Inc, Sun Pharmaceutical Industries Ltd, Sunovion Pharmaceuticals Inc, The Ritedose Corp, Akorn Operating Co Llc, Cipla Ltd, Luoxin Aurovitas Pharma Chengdu Co Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-2 adrenergic receptor | SINGLE PROTEIN | AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4003 | |||
| WDI | DR9801765 | |||
| DrugBank | DB13139 | |||
| PubChem: Thomson Pharma | 14798337 | |||
| PubChem | 123600 | |||
| Mcule | MCULE-7261473820 | |||
| LINCS | LSM-5480 | |||
| Nikkaji | J428.072E | |||
| PDBe | 68H | |||
| EPA CompTox Dashboard | DTXSID80187964 | |||
| DrugCentral | 1575 | |||
| ChemicalBook | CB0275903 | |||
| Guide to Pharmacology | 9816 | |||
| GSRS | 38cffb0e-8411-40a3-950d-8773957bbab7 | |||
| rxnorm | LEVALBUTEROL | XOPENEX | LEVALBUTEROL TARTRATE | LEVALBUTEROL HYDROCHLORIDE |
| KEGG Ligand | C11770 | |||
| ChEBI | 8746 | |||
| ZINC | ZINC000000007601 |
